ACRS Q1 2020 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

Q1 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1M-72.1% YoY

Gross Profit

$138,0009.8% margin

Operating Income

-$16M-1102.1% margin

Net Income

-$16M-1107.7% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+28.5%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$97M

Total Liabilities

$39M

Stockholders' Equity

$58M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$5M	-72.1%
Gross Profit	$138,000	$2M	-93.9%
Operating Income	-$16M	-$37M	+58.5%
Net Income	-$16M	-$38M	+58.5%

Revenue Segments

Laboratory Research Revenue

$1M85%

Other Revenue

$218,00015%